ES8406439A1 - Procedimiento de preparar compuestos 1,4-dihidropiridinicos. - Google Patents

Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Info

Publication number
ES8406439A1
ES8406439A1 ES517022A ES517022A ES8406439A1 ES 8406439 A1 ES8406439 A1 ES 8406439A1 ES 517022 A ES517022 A ES 517022A ES 517022 A ES517022 A ES 517022A ES 8406439 A1 ES8406439 A1 ES 8406439A1
Authority
ES
Spain
Prior art keywords
procedure
general formula
preparing
dihydropyridine compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517022A
Other languages
English (en)
Spanish (es)
Other versions
ES517022A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16696381A external-priority patent/JPS5867668A/ja
Priority claimed from JP259782A external-priority patent/JPS58121288A/ja
Priority claimed from JP2839182A external-priority patent/JPS58146565A/ja
Application filed by Maruko Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Publication of ES517022A0 publication Critical patent/ES517022A0/es
Publication of ES8406439A1 publication Critical patent/ES8406439A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES517022A 1981-10-19 1982-10-19 Procedimiento de preparar compuestos 1,4-dihidropiridinicos. Expired ES8406439A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16696381A JPS5867668A (ja) 1981-10-19 1981-10-19 1,4−ジヒドロピリジン誘導体
JP259782A JPS58121288A (ja) 1982-01-11 1982-01-11 1,4−ジヒドロピリジン誘導体
JP2839182A JPS58146565A (ja) 1982-02-24 1982-02-24 1,4−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
ES517022A0 ES517022A0 (es) 1984-08-16
ES8406439A1 true ES8406439A1 (es) 1984-08-16

Family

ID=27275435

Family Applications (2)

Application Number Title Priority Date Filing Date
ES517022A Expired ES8406439A1 (es) 1981-10-19 1982-10-19 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES527980A Expired ES8504127A1 (es) 1981-10-19 1983-11-30 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527980A Expired ES8504127A1 (es) 1981-10-19 1983-11-30 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Country Status (12)

Country Link
US (1) US4446325A (OSRAM)
KR (1) KR880002704B1 (OSRAM)
AU (1) AU555036B2 (OSRAM)
CA (1) CA1177079A (OSRAM)
CH (1) CH650498A5 (OSRAM)
DE (1) DE3238705A1 (OSRAM)
ES (2) ES8406439A1 (OSRAM)
FR (1) FR2514761B1 (OSRAM)
GB (1) GB2111978B (OSRAM)
IT (1) IT1189393B (OSRAM)
NL (1) NL194203C (OSRAM)
SE (1) SE442864B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
DE3514865A1 (de) * 1985-04-25 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
BR0109991A (pt) * 2000-04-11 2003-05-27 Sankyo Co Composição farmacêutica
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
CA2574958A1 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
AU2012303683B2 (en) 2011-08-26 2016-09-08 Wockhardt Limited Methods for treating cardiovascular disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
SE8205905L (sv) 1983-04-20
CH650498A5 (de) 1985-07-31
FR2514761A1 (fr) 1983-04-22
IT8249295A0 (it) 1982-10-18
AU8931782A (en) 1983-04-28
GB2111978A (en) 1983-07-13
ES517022A0 (es) 1984-08-16
FR2514761B1 (fr) 1985-09-06
GB2111978B (en) 1985-05-01
NL8204014A (nl) 1983-05-16
IT8249295A1 (it) 1984-04-18
CA1177079A (en) 1984-10-30
US4446325A (en) 1984-05-01
IT1189393B (it) 1988-02-04
ES527980A0 (es) 1985-04-16
SE8205905D0 (sv) 1982-10-18
NL194203B (nl) 2001-05-01
KR880002704B1 (ko) 1988-12-26
DE3238705C2 (OSRAM) 1989-11-09
SE442864B (sv) 1986-02-03
KR840001954A (ko) 1984-06-07
ES8504127A1 (es) 1985-04-16
NL194203C (nl) 2001-09-04
DE3238705A1 (de) 1983-07-14
AU555036B2 (en) 1986-09-11

Similar Documents

Publication Publication Date Title
ES8406439A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
IT1196553B (it) Composto di beclometasone monoidrato,composizioni che lo contengono e relativo procedimento di produzione
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
RU2000116633A (ru) Производные имидазола, обладающие ингибирующей активностью в отношении фарнезилтрансферазы, и способ их получения, промежуточные соединения, фармацевтическая композиция
ES8204428A1 (es) Procedimiento para preparar alfa-aril-1h-1,2,4-triazol-1- etanoles
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8105248A1 (es) Procedimiento para preparar derivados de trifenilalqueno
IT1196261B (it) Derivati nucleosidici e purinici 8-sostituiti
NL7804273A (nl) Aminodeoxyclavulanzuurderivaten met een anti-bacterielewerking, farmaceutische preparaten die een dergelijke verbinding bevatten alsmede werkwijzen ter bereiding van deze verbindingen.
ES8604711A1 (es) Un procedimiento para la obtencion de beta-feniletanoles sustituidos.
DK270578A (da) Surt alkalicitrat k6na6h3(c607h5)5,2-4 h2/, ogfremgangsmaade til fremstilling deraf
ES408276A1 (es) Procedimiento para la preparacion de 2-(furilmetil)-6,7 benzomorfanos.
ES8606321A1 (es) Un procedimiento para preparar un derivado de 2-hidroxi-3- (4-fenilpiperazimil)propoxi-benzofurano
CA2112690A1 (en) Amino acid derivative
KR830004219A (ko) 약리적 활성 펩티드
ES458176A1 (es) Procedimiento para la preparacion de derivados de indazolil-(4)-oxi-propanolamina.
BR8702013A (pt) Processo de preparacao de compostos carbonilados etilenicos
ES8600244A1 (es) Procedimiento de preparacion de nuevos derivados piridinicos y de sus sales de adicion acidas y cuaternarias
CA2130618A1 (en) Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
IT1197462B (it) Composizioni poliolefiniche stabilizzate e composti stabilizzanti adatti allo scopo
ES8303284A1 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ES8403463A1 (es) "un procedimiento para la preparacion de un compuesto de imidazol".
IT8520482A0 (it) Derivati di imminotiazolidina, processo per prepararli e composizioni farmaceutiche che licontengono.